Genenta Science Spa Stock Price Prediction

GNTA Stock  USD 4.78  0.01  0.21%   
At this time, the RSI of Genenta Science's share price is approaching 49. This usually indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Genenta Science, making its price go up or down.

Oversold Vs Overbought

49

 
Oversold
 
Overbought
The successful prediction of Genenta Science's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Genenta Science SpA, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Genenta Science's stock price prediction:
Wall Street Target Price
20.8005
Using Genenta Science hype-based prediction, you can estimate the value of Genenta Science SpA from the perspective of Genenta Science response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Genenta Science to buy its stock at a price that has no basis in reality. In that case, they are not buying Genenta because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Genenta Science after-hype prediction price

    
  USD 4.78  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Genenta Science Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Genenta Science's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.214.1510.81
Details
Naive
Forecast
LowNextHigh
0.105.0111.67
Details
2 Analysts
Consensus
LowTargetHigh
20.9323.0025.53
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details

Genenta Science After-Hype Price Prediction Density Analysis

As far as predicting the price of Genenta Science at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Genenta Science or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Genenta Science, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Genenta Science Estimiated After-Hype Price Volatility

In the context of predicting Genenta Science's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Genenta Science's historical news coverage. Genenta Science's after-hype downside and upside margins for the prediction period are 0.24 and 11.44, respectively. We have considered Genenta Science's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
4.78
4.78
After-hype Price
11.44
Upside
Genenta Science is very risky at this time. Analysis and calculation of next after-hype price of Genenta Science SpA is based on 3 months time horizon.

Genenta Science Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Genenta Science is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Genenta Science backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Genenta Science, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.48 
6.66
  0.64 
  0.03 
5 Events / Month
12 Events / Month
In about 5 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
4.78
4.78
0.00 
500.75  
Notes

Genenta Science Hype Timeline

Genenta Science SpA is currently traded for 4.78. The entity has historical hype elasticity of -0.64, and average elasticity to hype of competition of -0.03. Genenta is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 0.48%. %. The volatility of related hype on Genenta Science is about 11752.94%, with the expected price after the next announcement by competition of 4.75. About 39.0% of the company shares are held by company insiders. The book value of Genenta Science was currently reported as 0.92. The company recorded a loss per share of 0.51. Genenta Science SpA had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 5 days.
Check out Genenta Science Basic Forecasting Models to cross-verify your projections.

Genenta Science Related Hype Analysis

Having access to credible news sources related to Genenta Science's direct competition is more important than ever and may enhance your ability to predict Genenta Science's future price movements. Getting to know how Genenta Science's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Genenta Science may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
MOLNMolecular Partners AG(0.10)5 per month 5.10 (0) 9.61 (8.53) 52.92 
MNOVMediciNova 0.05 8 per month 4.27  0.11  14.50 (8.50) 61.30 
ANEBAnebulo Pharmaceuticals 0.03 5 per month 0.00 (0.04) 8.61 (11.48) 76.00 
CSBRChampions Oncology 0.34 7 per month 4.15 (0.02) 6.56 (7.11) 22.49 
CYTCyteir Therapeutics 0.09 2 per month 2.57  0.08  10.00 (5.26) 36.14 
PMVPPmv Pharmaceuticals(0.1)3 per month 2.00 (0.03) 3.75 (3.64) 13.98 
ELYMEliem Therapeutics 0.25 4 per month 0.00 (0.19) 6.21 (9.35) 34.87 
PHVSPharvaris BV(0.23)5 per month 2.99  0.08  7.76 (6.02) 21.41 
PEPGPepGen 0.39 8 per month 0.00 (0.25) 4.78 (9.02) 26.81 
MLYSMineralys Therapeutics, Common 0.14 8 per month 3.39 (0) 6.27 (5.79) 20.98 
JANXJanux Therapeutics(1.70)9 per month 2.59 (0.01) 6.87 (4.58) 15.08 
RZLTRezolute(0.28)7 per month 3.11 (0) 6.80 (5.54) 30.01 
GLSHGelesis Holdings 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
OPTOpthea 0.11 11 per month 3.86  0.02  8.65 (7.49) 24.20 
PRDSPardes Biosciences 0.02 3 per month 1.66  0.09  4.28 (2.59) 15.31 
ANTXAN2 Therapeutics(0.03)11 per month 1.86  0.08  3.73 (3.42) 28.03 
AVTEAerovate Therapeutics(0.02)3 per month 2.13  0.13  5.58 (3.86) 19.11 
ADAGAdagene 0.02 5 per month 0.00 (0.06) 8.13 (9.52) 37.93 

Genenta Science Additional Predictive Modules

Most predictive techniques to examine Genenta price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Genenta using various technical indicators. When you analyze Genenta charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Genenta Science Predictive Indicators

The successful prediction of Genenta Science stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Genenta Science SpA, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Genenta Science based on analysis of Genenta Science hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Genenta Science's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Genenta Science's related companies.
 2021 2022 2023 2024 (projected)
PB Ratio4.523.03.996.97
Capex To Depreciation1.844.410.320.31

Story Coverage note for Genenta Science

The number of cover stories for Genenta Science depends on current market conditions and Genenta Science's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Genenta Science is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Genenta Science's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Genenta Science Short Properties

Genenta Science's future price predictability will typically decrease when Genenta Science's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Genenta Science SpA often depends not only on the future outlook of the potential Genenta Science's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Genenta Science's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding18.2 M
Cash And Short Term Investments18.8 M
Shares Float11.2 M

Complementary Tools for Genenta Stock analysis

When running Genenta Science's price analysis, check to measure Genenta Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genenta Science is operating at the current time. Most of Genenta Science's value examination focuses on studying past and present price action to predict the probability of Genenta Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genenta Science's price. Additionally, you may evaluate how the addition of Genenta Science to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance